US 10208012
Compounds for treating inflammatory and hyperproliferative diseases
granted A61KA61K31/382A61K31/404
Quick answer
US patent 10208012 (Compounds for treating inflammatory and hyperproliferative diseases) held by The Board of Regents of the University of Texas System expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K31/382, A61K31/404, A61K31/538, A61K45/06